ENHERTU vs KANJINTI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. ENHERTU and KANJINTI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ENHERTU	KANJINTI
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	FAM-TRASTUZUMAB DERUXTECAN-NXKI	TRASTUZUMAB-ANNS
Manufacturer	Daiichi Sankyo Inc	Amgen Inc
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Breast Neoplasms, Gastrointestinal Neoplasms	Breast Neoplasms, Gastrointestinal Neoplasms

enhertu kanjinti

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

FAM-TRASTUZUMAB DERUXTECAN-NXKI

TRASTUZUMAB-ANNS

Manufacturer

Daiichi Sankyo Inc

Amgen Inc

Dosage forms

Injectable

Drug class

—

Boxed warning

Treats

Breast Neoplasms, Gastrointestinal Neoplasms

Frequently asked questions

What is the difference between Enhertu and Kanjinti?

Enhertu contains Fam-Trastuzumab Deruxtecan-Nxki, while Kanjinti contains Trastuzumab-Anns — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.